Parametric Portfolio Associates’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.07M Sell
62,590
-61,479
-50% -$2.31M ﹤0.01% 2407
2021
Q4
$5.28M Sell
124,069
-21,757
-15% -$911K ﹤0.01% 1829
2021
Q3
$6.46M Sell
145,826
-33,293
-19% -$1.53M ﹤0.01% 1660
2021
Q2
$10.2M Sell
179,119
-14,926
-8% -$1.06M 0.01% 1378
2021
Q1
$14.5M Sell
194,045
-12,198
-6% -$1M 0.01% 1377
2020
Q4
$17.8M Buy
206,243
+26,695
+15% +$1.97M 0.01% 1136
2020
Q3
$11M Buy
179,548
+41,180
+30% +$2.09M 0.01% 1330
2020
Q2
$5.75M Buy
138,368
+46,676
+51% +$1.69M ﹤0.01% 1778
2020
Q1
$2.63M Buy
91,692
+54,421
+146% +$3.15M ﹤0.01% 2203
2019
Q4
$2.69M Sell
37,271
-11,478
-24% -$1.41M ﹤0.01% 2492
2019
Q3
$6.84M Buy
48,749
+1,087
+2% +$182K 0.01% 1776
2019
Q2
$8.73M Buy
47,662
+11,323
+31% +$1.93M 0.01% 1570
2019
Q1
$5.78M Buy
36,339
+13,131
+57% +$1.9M 0.01% 1877
2018
Q4
$2.22M Buy
23,208
+598
+3% +$68.4K ﹤0.01% 2516
2018
Q3
$3.19M Sell
22,610
-1,038
-4% -$160K ﹤0.01% 2367
2018
Q2
$3.7M Buy
23,648
+27
+0.1% +$4.24K ﹤0.01% 2217
2018
Q1
$3.81M Sell
23,621
-3,280
-12% -$557K ﹤0.01% 2130
2017
Q4
$4.43M Buy
26,901
+5,204
+24% +$505K ﹤0.01% 2004
2017
Q3
$1.35M Sell
21,697
-838
-4% -$65.8K ﹤0.01% 2851
2017
Q2
$1.79M Sell
22,535
-2,041
-8% -$148K ﹤0.01% 2619
2017
Q1
$1.75M Buy
24,576
+5,842
+31% +$342K ﹤0.01% 2533
2016
Q4
$957K Sell
18,734
-5,781
-24% -$272K ﹤0.01% 2856
2016
Q3
$1.13M Buy
24,515
+6,829
+39% +$278K ﹤0.01% 2726
2016
Q2
$533K Sell
17,686
-3,857
-18% -$129K ﹤0.01% 3154
2016
Q1
$691K Buy
21,543
+13,810
+179% +$486K ﹤0.01% 3157
2015
Q4
$451K Buy
+7,733
New +$383K ﹤0.01% 3321

Other funds holding SAGE